Publication:
Differences in Eysenck's Personality Dimensions between a Group of Breast Cancer Survivors and the General Population.

Loading...
Thumbnail Image

Date

2019-04-05

Authors

Garcia-Torres, Francisco
Castillo-Mayen, Rosario

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

MDPI
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Cancer may influence personality in patients and survivors. However, the possible relations between the treatments that the patients have undergone and the personality in survivors are not clear. This study aimed to establish the differences in personality between a group of breast cancer survivors and a control group, and to test the predictive utility of the treatments on the personality traits in survivors. Thirty breast cancer survivors and thirty participants from the general population completed the Eysenck personality questionnaire-revised (EPQ-R) and a socio-demographic questionnaire. Survivors had lower scores on extraversion and higher scores on neuroticism than the control group, but these differences were not significant. However, differences in psychoticism were significant, with higher scores in the survivor group. Breast-conserving therapy predicted extraversion while breast reconstruction predicted psychoticism. These results suggest that the physical consequences of surgery may lead to social and psychological impairments in this group of patients.

Description

MeSH Terms

Adult
Breast neoplasms
Cancer survivors
Case-control studies
Female
Humans
Male
Personality inventory
Surveys and questionnaires

DeCS Terms

Estudios de casos y controles
Inventario de personalidad
Neoplasias de la mama
Supervivientes de cáncer

CIE Terms

Keywords

Breast cancer, Oncology, Personality, Psychoticism, Survivorship

Citation

García-Torres F, Castillo-Mayén R. Differences in Eysenck's Personality Dimensions between a Group of Breast Cancer Survivors and the General Population. Int J Environ Res Public Health. 2019 Apr 8;16(7):1240